Lisanti Capital Growth, LLC Summit Therapeutics Inc. Transaction History
Lisanti Capital Growth, LLC
- $297 Million
- Q1 2025
A detailed history of Lisanti Capital Growth, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 53,850 shares of SMMT stock, worth $1.39 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
53,850Holding current value
$1.39 Million% of portfolio
0.35%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$631 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$301 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$204 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$170 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$125 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.2B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...